Backing UK Innovation with the £100M CIC Opportunity Fund 🚀
We’re pleased to launch the CIC Opportunity Fund, a £100 million growth fund anchored by @avivainvestors and @BPatientCap, with cornerstone commitments of £15 million and £20 million, respectively. This fund is designed to provide crucial scale-up financing for the UK’s deep tech and life sciences companies - helping them navigate the critical next stage of growth and remain competitive on a global stage.
The UK is home to world-class research and breakthrough innovation, but too often, companies struggle to secure the funding needed to scale. With investments of up to £20 million per company, we aim to bridge this gap, ensuring that more IP-rich, high-impact businesses can grow and thrive in the UK.
This investment also reflects the strong commitment of Aviva Investors and British Patient Capital to the UK’s innovation ecosystem. Their support strengthens Cambridge’s position as a world-leading science and technology hub and aligns with broader efforts to develop the Oxford-Cambridge Growth Corridor.
We’re excited to partner with investors who share our vision and look forward to supporting the next generation of globally competitive technology companies.
#CICOpportunityFund #VentureCapital #DeepTech #LifeSciences #Innovation #ScaleUp #Cambridge
So excited to offer this brilliant scholarship to women in Data Intensive Science!
Please share this with your academic communities, and encourage your students to apply!
Are you coming to #BioBeat24: Driving solutions in neurodegeneration with digital, 16 May, Sainsbury Wellcome Centre, London? Chairs are Alison Cave @MHRAgovuk and Jia-Yi Har @CathayHealth fund. Info & to register: https://t.co/CXvEUIR3sp
Thanks for support @UKDRI@SWC_Neuro
📣 Attention all deep-tech and life science startup founders! Applications for the I.E.C.T. – Summer School 2024 are now open!
Hosted by I.E.C.T. – Hermann Hauser and https://t.co/l4h4HbZBfy Info and to register at https://t.co/8XLsCkLS0t @IECT_HH
Hope to see you there!
The latest @Innovation_F event will focus on Cell and Gene Therapy!
Academics, entrepreneurs and companies will lead the discussion on how we can translate this technology into clinics. Marylebone, London 6 June 2024
https://t.co/x9pJGmSrVe #CGT#event
Mentor Highlight: Miranda Weston-Smith
The impulse programme wouldn't be what it is without the amazing contribution our mentors make. Thank you for being part of impulse since the beginning @BioBeatUK#IECambridge#entrepreneurship#innovation#mentor
The countdown has begun to this week’s Women in STEM Festival at #MurrayEdwards - a major national conference with world-renowned speakers probing the barriers facing girls and women in STEM studies, research and careers - & forging practical solutions. #MurrayEdwardsSTEMFest
Following this year's #BioBeat23 conference, we are delighted to host a follow-up workshop which aims to help businesses gain a better understanding of the role IP plays in getting investment or deal ready.
8.30 AM, 16 June 2023, Clayton Hotel Cambridge
https://t.co/JluXISHHrz
Following this year's #BioBeat23 conference, we are delighted to host a follow-up workshop which aims to help businesses gain a better understanding of the role IP plays in getting investment or deal ready.
8.30 AM, 16 June 2023, Clayton Hotel Cambridge
https://t.co/JluXISHHrz
Appleyard Lees is proud to sponsor #BioBeat23. Cambridge-based patent attorneys Barbara Fleck, Appleyard Lees partner, and Claire Devine, Appleyard Lees associate, will attend.
'I’m curious to know, how did you get into biotech investing?' was a great place for Miranda Weston-Smith to start the conversation with @molotova_a which forms the basis of the guest blog on the One Nucleus website ahead of BioBeat23…https://t.co/Z1ilPgE6ke
#Alisa#Molotova, #Investment Manager at #Martlet Capital and my co-organiser of BioBeat23, talk about her perspective on ##healthcare#investment at: https://t.co/lrn78Ut4eQ
Register for BioBeat23, 13.30-18.5, 18 May, Cambridge Union at: https://t.co/wdtIUmnMW4